Insulet has been granted a patent for a drug delivery system comprising an on-body pump device and a secondary unit. The secondary unit is designed to receive a prefilled cartridge containing a liquid drug, expel the drug, and deliver it to the pump device’s reservoir. GlobalData’s report on Insulet gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Insulet Corp - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Insulet, Wearable drug delivery devices was a key innovation area identified from patents. Insulet's grant share as of May 2024 was 24%. Grant share is based on the ratio of number of grants to total number of patents.

Drug delivery system with on-body pump and secondary unit

Source: United States Patent and Trademark Office (USPTO). Credit: Insulet Corp

A recently granted patent (Publication Number: US11992653B2) discloses a system comprising an on-body pump device with a reservoir, pump mechanism, and fluid pathway, designed to be attached to a user's skin. The system includes a secondary unit with a variable fill mechanism that can receive a prefilled cartridge containing a liquid drug. The secondary unit is capable of expelling the liquid drug from the cartridge and delivering it to the reservoir of the on-body pump device. The system also features a needle insertion mechanism to enable the delivery of the liquid drug into the user's skin.

Furthermore, the patent describes an on-body pump device with multiple reservoirs and pump mechanisms, each capable of pumping a different fluid. The device includes a flow regulator valve with inner and outer valves to control the flow rate of each fluid independently. A cannula is fluidly coupled to the flow regulator valve, allowing the delivery of the fluids to the user. The device also features a septum for receiving a secondary unit, enabling the delivery of the fluids to the respective reservoirs. Additionally, a secondary unit is detailed in the patent, with an opening for a prefilled cartridge, a variable fill mechanism, and a needle insertion mechanism to actuate the introducing needle of the on-body pump device. The variable fill mechanism includes a visual indicator to display the fill volume of the liquid drug within the reservoir, providing a user-friendly and efficient drug delivery system.

To know more about GlobalData’s detailed insights on Insulet, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.